Correlation Between Disc Medicine and Entrada Therapeutics

Can any of the company-specific risk be diversified away by investing in both Disc Medicine and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Disc Medicine and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Disc Medicine and Entrada Therapeutics, you can compare the effects of market volatilities on Disc Medicine and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Disc Medicine with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Disc Medicine and Entrada Therapeutics.

Diversification Opportunities for Disc Medicine and Entrada Therapeutics

0.82

Correlation Coefficient

Disc Medicine  Entrada Therapeutics

Very poor diversification

The 3 months correlation between Disc and Entrada is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Disc Medicine and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Disc Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Disc Medicine are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Disc Medicine i.e., Disc Medicine and Entrada Therapeutics go up and down completely randomly.

Pair Corralation between Disc Medicine and Entrada Therapeutics

Given the investment horizon of 90 days Disc Medicine is expected to generate 0.78 times more return on investment than Entrada Therapeutics. However, Disc Medicine is 1.28 times less risky than Entrada Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  5,979  in Disc Medicine on August 4, 2025 and sell it today you would earn a total of  2,643  from holding Disc Medicine or generate 44.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Disc Medicine  vs.  Entrada Therapeutics

Disc Medicine

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Disc Medicine are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Disc Medicine displayed solid returns over the last few months and may actually be approaching a breakup point.

Entrada Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Disc Medicine and Entrada Therapeutics

The main advantage of trading using opposite Disc Medicine and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Disc Medicine position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.

The idea behind Disc Medicine and Entrada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.